Jonathan Levitt

Frier Levitt is proud to be attending Asembia's AXS26 Summit next week. If you’ll be there, stop by our booth #1723 to connect with our team or schedule a meeting with Co-Founding Partner Jonathan Levitt, along with Partners Jesse Dresser and Matt Modafferi. Bring your questions. Our attorneys are available to discuss the regulatory, litigation, and compliance issues shaping the specialty pharmacy industry. Schedule a meeting with our attorneys here: bit.ly/4cGFjmX See you there!

The DOJ’s $62.85 million settlement with Seoul Medical Group sends an unmistakable message: false diagnosis codes submitted to inflate Medicare Advantage risk scores will be pursued aggressively. 🔗Read what happened, and what value-based care providers in risk-adjusted capitated arrangements must do now: bit.ly/3QGdG6d #MedicareAdvantage #HealthcareLaw #FalseClaimsAct #RiskAdjustment #ValueBasedCare #HealthcareCompliance #FrierLevitt

Paying a CMS overpayment demand without appealing? It could backfire. 🔗 Key risks healthcare providers should know bit.ly/4vxKEG9 #HealthcareLaw #Medicare #AuditDefense #FrierLevitt

Multiple insurers. No clear payor. The “finger-pointing” problem is costing providers time and revenue. 🔗 Here’s what you need to know bit.ly/4tkOoZK #HealthcareLaw #RevenueCycle #FrierLevitt

AI is shaping workforce decisions in healthcare. But what are the legal risks? New insights from a Medical Economics podcast 🎧 Listen here: bit.ly/4sBzfT0 #AI #Healthcare #EmploymentLaw #FrierLevitt

As regulatory complexity and enforcement activity continue to impact the specialty pharmacy industry, stakeholders are navigating increased compliance and operational challenges. At the Asembia 2026 Specialty Pharmacy Summit, Partner Matt Modafferi will be meeting with pharmacies, manufacturers, and industry stakeholders to address regulatory requirements, compliance strategies, and evolving enforcement risks. If you’re attending and working through these challenges, connect with Matt at Asembia by clicking here: bit.ly/4uAr5wh

PBM audits continue to pose significant operational and financial risks for pharmacies. As enforcement activity increases and PBM provider manuals evolve, pharmacies must stay ahead of new requirements and expectations. Join Frier Levitt Partner Harini Bupathi on May 12 at 12:30PM ET. for a practical, no-nonsense breakdown of what’s changing in 2026—and how your pharmacy can stay protected. This webinar will cover how to identify and proactively address common pressure points during PBM audits, navigate new provisions in 2026 provider manuals and agreements that could impact your business, and leverage resources and tools to effectively respond to audits and minimize the risk of network termination. Who should attend: Pharmacy owners, operators, compliance officers, billing and reimbursement teams, and anyone responsible for PBM relationships, provider manual compliance, or network participation. Don’t wait until an audit hits. Register today and get ahead of what PBMs are looking for now. bit.ly/4e8qBHK #PBMAudit #PharmacyLaw #NetworkTermination #FrierLevitt

DEA’s Operation Meltdown signals increased enforcement against illegal online pharmacies. What does it mean for compliant providers and pharmacies? 🔗 Read more: bit.ly/4bICAdC #DEA #HealthcareLaw #PharmacyCompliance #FrierLevitt

Physicians: don’t sign a noncompete without understanding the risks. From evaluating enforceability to negotiating protections with a new employer, taking the right steps early can make all the difference. 🔗 Watch the full interview: bit.ly/4dfSkpP #HealthcareLaw #EmploymentLaw #Physicians #FrierLevitt

340B manufacturer data demands are increasing. Learn how claim-level data requirements are impacting covered entities and pharmacies. 🔗 Read more: bit.ly/3NtaJ89 #340B #HealthcareLaw #Pharmacy #FrierLevitt

The specialty pharmacy landscape continues to face increasing pressure from PBM practices, reimbursement constraints, and network access barriers. At the Asembia 2026 Specialty Pharmacy Summit, Co-Founding Partner Jonathan Levitt will be meeting with pharmacies, manufacturers and industry stakeholders to address these challenges, including PBM reimbursement disputes, and network participation issues. With deep experience challenging PBM conduct through regulatory advocacy and litigation, Jon helps pharmacies identify discrepancies, enforce their rights, and pursue meaningful outcomes. If you’re attending and dealing with these issues, let’s connect. Click here to schedule a meeting with Jon: bit.ly/4uAr5wh

CMS has overhauled reimbursement for skin substitutes. Flat fee payments + no reimbursement for wastage = major impact on providers. Here’s what it means for compliance, audits, and revenue: bit.ly/4c8EKU2 #Medicare #HealthcareLaw #WoundCare #Reimbursement #FrierLevitt

PBM audits are increasingly focusing on prior authorizations, and pharmacies are being scrutinized more closely than ever. Learn where pharmacies face risk and how to avoid recoupments and audit findings. Read more: bit.ly/40Z5xMf #HealthcareLaw #PBM #Pharmacy #FrierLevitt

Medicare payment suspensions are rising, and labs are a key target. Learn what triggers a suspension and how to respond to protect your revenue and operations. Read more: bit.ly/4c5KnCk #Medicare #HealthcareCompliance #Laboratories #AuditDefense #FrierLevitt

Physician noncompetes remain governed by state law, not federal rule. From enforceability to structuring agreements across multiple states, understanding the nuances is critical for healthcare organizations. Read more: bit.ly/4bI3l0t #HealthcareLaw #EmploymentLaw #NonCompete #FrierLevitt

DOJ secures $31M judgment in healthcare kickback case. From marketing arrangements to telehealth prescribing and copay practices, understanding where enforcement is focused is critical. 🔗 Read more: bit.ly/41s0BQ8 #HealthcareLaw #FCA #AKS #Telehealth #FrierLevitt

Update: New Jersey is one step closer to expanding independent practice authority for Advanced Practice Nurses, but with important limitations. Key changes include higher experience requirements, narrower scope, and limits on aesthetic services. Learn what it means: bit.ly/4t11kU5 #HealthcareLaw #APN #NewJersey #FrierLevitt

Frier Levitt's Advocacy & Government Affairs Practice Group has a message for physician practice leaders and medical association executives heading into this election year: Your business plan is incomplete without an advocacy strategy. Read more about: ✔ Why the return on a well-executed advocacy initiative routinely outpaces contract renegotiation ✔ How prior authorization reform, payor tactics, and scope-of-practice rules represent common ground across specialties ✔ Why cross-specialty coalitions are strategically powerful — and more achievable than practices realize ✔ How election-year dynamics create a unique window for physician voices to be heard Frier Levitt works with large physician practices and membership associations to develop advocacy initiatives and advance policy objectives at the state and federal level. 🔗 bit.ly/4cJeO28 #PhysicianAdvocacy #GovernmentAffairs #HealthcarePolicy #PriorAuthorization #PhysicianPractice #HealthLaw #FrierLevitt

Medicare payment suspensions are reshaping provider risk in 2026. CMS is using data analytics and documentation gaps to freeze payments, often without a fraud finding. 🔗 Read more about what providers should be doing now to assess risk, strengthen documentation, and respond effectively when CMS intervenes. bit.ly/4lMqJyp #Medicare #HealthcareCompliance #AuditDefense

AI is reshaping hiring and layoffs, but it may also increase legal risk. Employers using AI should expect increased scrutiny, particularly where decisions may have a disparate impact on protected groups. As AI adoption grows, so does the importance of thoughtful implementation and legal oversight. 🔗 Watch the full interview with Medical Economics: bit.ly/4dwKvvQ #EmploymentLaw #AI #HRCompliance #FrierLevitt